Patent classifications
B01J13/20
DEVICE FOR PREPARATION OF EXPANDED MICROSPHERES
A device includes a heating zone having an inlet, and an outlet, a pump upstream of and in fluid communication with the heating zone, and capable of generating above-atmospheric pressure in the heating zone; an element for heating the heating zone; an expansion zone with an inlet and an outlet, said inlet of the expansion zone being connected to the outlet of the heating zone in such a way that a pressure drop is created, such that the expansion zone is at a lower pressure than the heating zone; and a back pressure generator downstream of the expansion zone configured to create a variable counter pressure in the expansion zone.
Nanocomposites and nanoagents for detection and treatment of a target of interest and methods of making and using same
A nanocomposite for detection and treatment of a target of interest including tumor cells or pathogens includes at least one nanostructure, each nanostructure having a core and a shell surrounding the core; a reporter assembled on the shell of each nanostructure; and a layer of a treating agent and a targeting agent conjugated to the reporter. In use, the nanocomposite targets to the target of interest according to the targeting agent and releases the treating agent and the nanostructure therein for therapeutic treatment of the target of interest, and the target of interest transmits at least one signature responsive to the reporter for detection of the target of interest.
Nanocomposites and nanoagents for detection and treatment of a target of interest and methods of making and using same
A nanocomposite for detection and treatment of a target of interest including tumor cells or pathogens includes at least one nanostructure, each nanostructure having a core and a shell surrounding the core; a reporter assembled on the shell of each nanostructure; and a layer of a treating agent and a targeting agent conjugated to the reporter. In use, the nanocomposite targets to the target of interest according to the targeting agent and releases the treating agent and the nanostructure therein for therapeutic treatment of the target of interest, and the target of interest transmits at least one signature responsive to the reporter for detection of the target of interest.
LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME
Provided are a liposome composition which has a practically required long-term preservation stability, and which has a release rate of a drug on the order of several tens of hours due to releasability of a drug being able to be suitably controlled by rendering an inner water phase hyper-osmotic; and a method for producing the same. According to the present invention, it is possible to provide a liposome composition, including liposomes each of which has an inner water phase and an aqueous solution which constitutes an outer water phase and in which the liposomes are dispersed, in which the content of cholesterols is 10 mol % to 35 mol % with respect to the total amount of lipid components in the liposome composition, and each of the liposomes encapsulates a drug in a dissolved state, and an osmotic pressure of the inner water phase is 2-fold to 8-fold relative to the osmotic pressure of the outer water phase.
LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME
Provided are a liposome composition which has a practically required long-term preservation stability, and which has a release rate of a drug on the order of several tens of hours due to releasability of a drug being able to be suitably controlled by rendering an inner water phase hyper-osmotic; and a method for producing the same. According to the present invention, it is possible to provide a liposome composition, including liposomes each of which has an inner water phase and an aqueous solution which constitutes an outer water phase and in which the liposomes are dispersed, in which the content of cholesterols is 10 mol % to 35 mol % with respect to the total amount of lipid components in the liposome composition, and each of the liposomes encapsulates a drug in a dissolved state, and an osmotic pressure of the inner water phase is 2-fold to 8-fold relative to the osmotic pressure of the outer water phase.
PROCESSES FOR PREPARING SILICA-CARBON ALLOTROPE COMPOSITE MATERIALS AND USING SAME
The present document describes a carbon allotrope-silica composite material comprising a silica microcapsule comprising a silica shell having a thickness of from about 50 nm to about 500 μm, and a plurality of pores, said shell forming a capsule having a diameter from about 0.2 μm to about 1500 μm, and having a density of about 0.001 g/cm3 to about 1.0 g/cm3, wherein said shell comprises from about 0% to about 70% Q3 configuration, and from about 30% to about 100% Q4 configuration, or wherein said shell comprises from about 0% to about 60% T2 configuration and from about 40% to about 100% T3 configuration, or wherein said shell comprises a combination of T and Q configurations thereof, and wherein an exterior surface of said capsule is covered by a functional group; a carbon allotrope attached to said silica microcapsule. Also described is a carbon allotrope-silica composite material comprising a carbon allotrope attached to a silica moiety comprising a silica nanoparticle having a diameter from about 5 nm to about 1000 nm, wherein an exterior surface of said silica nanoparticle is covered by a functional group.
PROCESSES FOR PREPARING SILICA-CARBON ALLOTROPE COMPOSITE MATERIALS AND USING SAME
The present document describes a carbon allotrope-silica composite material comprising a silica microcapsule comprising a silica shell having a thickness of from about 50 nm to about 500 μm, and a plurality of pores, said shell forming a capsule having a diameter from about 0.2 μm to about 1500 μm, and having a density of about 0.001 g/cm3 to about 1.0 g/cm3, wherein said shell comprises from about 0% to about 70% Q3 configuration, and from about 30% to about 100% Q4 configuration, or wherein said shell comprises from about 0% to about 60% T2 configuration and from about 40% to about 100% T3 configuration, or wherein said shell comprises a combination of T and Q configurations thereof, and wherein an exterior surface of said capsule is covered by a functional group; a carbon allotrope attached to said silica microcapsule. Also described is a carbon allotrope-silica composite material comprising a carbon allotrope attached to a silica moiety comprising a silica nanoparticle having a diameter from about 5 nm to about 1000 nm, wherein an exterior surface of said silica nanoparticle is covered by a functional group.
METHOD FOR PREPARING VESICLE, HOLLOW NANOSTRUCTURE, AND METHOD FOR PREPARING THE SAME
The present disclosure provides a method for preparing a vesicle, a hollow nanostructure, and a method for preparing the same. The preparation method of the vesicle includes: mixing and evenly stirring an aqueous solution of cetyl trimethyl ammonium bromide and an aqueous solution of tetraphenylethylene-bisphenol A; and allowing a stirred aqueous solution including cetyl trimethyl ammonium bromide and tetraphenylethylene-bisphenol A to stand for a first preset period to obtain an aggregate vesicle of cetyl trimethyl ammonium bromide and tetraphenylethylene-bisphenol A.
HOLLOW PARTICLES
To provide hollow particles excellent in performance stability in a high-humidity environment and low in relative permittivity. Hollow particles which comprise a shell containing a resin and a hollow portion surrounded by the shell, wherein the shell contains, as the resin, a polymer in which from 70 parts by mass to 100 parts by mass of a crosslinkable monomer unit is contained in 100 parts by mass of all monomer units; wherein a void ratio is 60% or more; wherein a content of a surfactant present on a surface of the hollow particles is 200 ppm or less; and wherein a relative permittivity at a frequency of 1 MHz is 1.6 or less.
METHODS, SYSTEMS, AND APPARATUS FOR ENCAPSULATING A SEQUESTRATION MEDIUM
An apparatus for encapsulating a material includes a first channel in fluid communication with a source of a material for encapsulation, at least one second channel in fluid communication with a source of a photopolymerizable compound, and at least one third channel in fluid communication with a source of an encapsulating fluid. Flow of the photopolymerizable compound into the first channel produces sheath flow in the first channel such that the material is within the polymerizable compound. Addition of the encapsulating fluid produces encapsulation precursors. Upon irradiation via a UV-radiation source, the photopolymerizable compound in the encapsulation precursor forms a polymer shell encapsulating the material for encapsulation. Materials such as nanoparticle organic hybrid materials (NOHMs) and a metal-organic frameworks (MOFs) can be thus encapsulated as carbon sequestration micro particles, as the polymer shell is permeable by gases such as carbon dioxide but selectively rejects other compounds such as water.